First patient dosed in Nouscom colorectal cancer study
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, says the first patient…
November 15, 2022 - 3 minutes
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, says the first patient…